2025-12-6 10.1.6.65
Code of China Chinese Classification Professional Classification ICS Classification Latest News Value-added Services

Position: Chinese Standard in English/T/ZSA 95-2021
T/ZSA 95-2021   Requirements for quality control on chimeric antigen receptor T cell products clinical research (English Version)
Standard No.: T/ZSA 95-2021 Status:valid remind me the status change

Email:

Target Language:English File Format:PDF
Word Count: Translation Price(USD): remind me the price change

Email:

Implemented on:2021-12-25 Delivery:

→ → →

,,2021-12-25,5AF05C4E432EB17A1755059990423
Standard No.: T/ZSA 95-2021
English Name: Requirements for quality control on chimeric antigen receptor T cell products clinical research
Chinese Name: 嵌合抗原受体T细胞制品临床研究质量控制要求
Chinese Classification: C27    Biological agent and blood products
Professional Classification: T/    Social Organization Standard
Source Content Issued by: Zhongguancun Standardization Association
Issued on: 2021-12-24
Implemented on: 2021-12-25
Status: valid
Target Language: English
File Format: PDF
本文件给出了嵌合抗原受体T细胞制品临床研究过程的质量控制要求及其他要求。
本文件适用于临床试验/研究机构、申办者、监查和稽查机构开展的嵌合抗原受体T细胞制品临床研究质量控制、监查和稽查,包括嵌合抗原受体T细胞制品注册临床试验及研究者发起的探索性临床研究。
Code of China
Standard
T/ZSA 95-2021  Requirements for quality control on chimeric antigen receptor T cell products clinical research (English Version)
Standard No.T/ZSA 95-2021
Statusvalid
LanguageEnglish
File FormatPDF
Word Count words
Price(USD)
Implemented on2021-12-25
Deliveryvia email in business day
Detail of T/ZSA 95-2021
Standard No.
T/ZSA 95-2021
English Name
Requirements for quality control on chimeric antigen receptor T cell products clinical research
Chinese Name
嵌合抗原受体T细胞制品临床研究质量控制要求
Chinese Classification
C27
Professional Classification
T/
ICS Classification
Issued by
Zhongguancun Standardization Association
Issued on
2021-12-24
Implemented on
2021-12-25
Status
valid
Superseded by
Superseded on
Abolished on
Superseding
Language
English
File Format
PDF
Word Count
words
Price(USD)
Keywords
T/ZSA 95-2021, T/ZSAT 95-2021, TZSAT 95-2021, T/ZSA95-2021, T/ZSA 95, T/ZSA95, T/ZSAT95-2021, T/ZSAT 95, T/ZSAT95, TZSAT95-2021, TZSAT 95, TZSAT95
Introduction of T/ZSA 95-2021
本文件给出了嵌合抗原受体T细胞制品临床研究过程的质量控制要求及其他要求。
本文件适用于临床试验/研究机构、申办者、监查和稽查机构开展的嵌合抗原受体T细胞制品临床研究质量控制、监查和稽查,包括嵌合抗原受体T细胞制品注册临床试验及研究者发起的探索性临床研究。
Contents of T/ZSA 95-2021
About Us   |    Contact Us   |    Terms of Service   |    Privacy   |    Cancellation & Refund Policy   |    Payment
Tel: +86-10-8572 5655 | Fax: +86-10-8581 9515 | Email: coc@codeofchina.com | QQ: 672269886
Copyright: Beijing COC Tech Co., Ltd. 2008-2040
 
 
Keywords:
T/ZSA 95-2021, T/ZSAT 95-2021, TZSAT 95-2021, T/ZSA95-2021, T/ZSA 95, T/ZSA95, T/ZSAT95-2021, T/ZSAT 95, T/ZSAT95, TZSAT95-2021, TZSAT 95, TZSAT95